KUALA LUMPUR: KPJ Healthcare Bhd
’s net profit increased to RM365.92 million in the financial year ended Dec 31, 2025 (FY2025) from RM353.81 million a year ago.
Revenue rose to RM4.25 billion against RM3.89 billion a year earlier, largely contributed by a higher number of patients’ visits, a Bursa Malaysia filing said today.
KPJ Healthcare declared a first interim dividend of 1.35 sen per share for FY2026, totalling RM59.2 million, payable April 17, 2026.
It said operational beds increased four per cent year-on-year as capacity expansion progressed, while surgical cases rose 11 per cent and average revenue per inpatient increased seven per cent, reflecting continued growth in patient activity across the network.
KPJ Healthcare said it remains focused on balancing utilisation, clinical quality and cost discipline amid ongoing workforce and cost pressures affecting the healthcare sector.
"FY2025 reflects clear progress in strengthening revenue quality, operating leverage and system integration across the group. Growth, supported by resilient patient demand, improving case mix and deeper specialist capability, is shifting KPJ toward higher-acuity, value-generative services,” KPJ Healthcare president/managing director Chin Keat Chyuan said in a separate statement today.
He added that the next phase of KPJ Healthcare’s growth would be driven by the convergence of artificial intelligence, genomics and value-based care within a unified operating model.
It remains cautiously optimistic about its 2026 prospects, supported by its ongoing asset optimisation programme, continued capacity expansion and sustained focus on enhancing operational efficiency. - Bernama
